Lumigan, Allergan’s Intraocular Pressure Drug, Received FDA Approval lumigan ， Allergan公司的眼內壓的藥物，收到了FDA的批准
The FDA has approved Allergan's once-daily prescription eye drop Lumigan as a first-line treatment for elevated intraocular pressure associated with open-angle glaucoma or ocular hypertension. FDA已批准Allergan公司的每日一次處方眼藥水lumigan作為第一線治療方法，為高眼壓與開角型青光眼和高眼壓症。
The Lumigan first-line indication is in addition to the product's already established use as a second-line treatment, for which the FDA approved the drug in 2001.該lumigan第一線的跡象，除了產品的，已建立使用作為第二線治療，而FDA批准該藥於2001年。
Since its introduction as a first-line treatment, Lumigan has been widely prescribed by eye care professionals to reduce elevated intraocular pressure (IOP) in patients who were intolerant of other IOP-lowering medications or who did not have a sufficient reduction in IOP in multiple measurements using other medications for the disorder.自推出以來，作為第一線治療， lumigan已被廣泛處方的眼睛護理專業人員，以減少高眼壓（眼壓） ，在病人不能容忍其他眼壓降低藥品或不具有足夠的降低眼壓，在多測量用其他藥物為騷亂。
Elevated IOP represents a major risk factor for vision loss associated with open-angle glaucoma; the higher the IOP, the greater the likelihood of optic nerve damage, which can lead to vision loss and potential blindness.眼壓增高的一大危險因素，視力喪失與開角型青光眼;越高，眼壓，可能性就越大視神經損傷，可導致視力喪失和潛在的盲目性。
Source: Pharmaceutical-Business-Review資料來源：製藥企業審查
You may also like to read您可能還喜歡讀
- Alcon Gets FDA Approval for Travatan-Z Which Reduce Elevated Intraocular Pressure alcon獲得FDA批准travatan - Z的，其中減少高眼壓
- Phase II Clinical Trial of Mifepristone an Eye Drop Treatment for Steroid Associated Elevated Intraocular Pressure第二期臨床試驗米非司酮一種眼藥水治療類固醇相關的高眼壓
- IntraLase Gets Approval to Sell Femtosecond Laser System in Taiwan IntraLase公司獲批准出售飛秒激光系統在台灣
- Hope for Age Related Macular Degeneration with Lucentis希望為年齡相關性黃斑變性與Lucentis藥物
- Lucentis - Wet Macular Degeneration Drug is Highly Successful in Clinical Trials Lucentis藥物-濕性黃斑變性的藥物，是非常成功的臨床試驗
- STAAR Seeks FDA Approval of Visian TICL Implantable Contact Lens For Nearsightedness and Astigmatism Treatment staar尋求FDA批准的visian ticl植入式隱形眼鏡為遠視和散光的治療
- Diabetes Drug Avandia Causing Macular Edema糖尿病藥物文迪雅引起黃斑部水腫
- Eye Drug Lucentis Recommended by UK's NICE to Treat Wet AMD眼科藥物Lucentis藥物的推薦，由英國的尼斯治療濕的AMD
- Israel's Biotech Firm Sells Eye Treatment to Pfizer以色列的生物科技公司銷售眼科治療，以輝瑞
- Advanced Technique to Control Glaucoma先進的技術，以控制青光眼
